Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-01-31T18:57:07.740Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine, relapse, and adverse events: a 10-year electronic cohort study in Canada: commentary: author response

Published online by Cambridge University Press:  30 January 2025

Shawn Halayka  and
Lloyd Balbuena Open the ORCID record for Lloyd Balbuena [Opens in a new window]
Shawn Halayka
Affiliation:
Prince Albert, Saskatchewan, Canada
Lloyd Balbuena*
Affiliation:
Department of Psychiatry, College of Medicine, University of Saskatchewan, Saskatoon, Canada
*
Correspondence: Lloyd Balbuena. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
The British Journal of Psychiatry , Volume 226 , Issue 1 , January 2025 , pp. 55
Check for updates
Copyright
Copyright © The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Balbuena, L, Halayka, S, Lee, A, Ahmed, AG, Hinz, T, Kolla, N, et al. Clozapine, relapse, and adverse events: a 10-year electronic cohort study in Canada. Br J Psychiatry [Epub ahead of print] 18 Sep 2024. Available from: https://doi.org/10.1192/bjp.2024.140.CrossRefGoogle ScholarPubMed
Lambert, PC. STPM3: Stata Module to Fit Flexible Parametric Survival Models. Statistical Software Components. 21 Feb 2024 edn. Boston College Department of Economics, 2023.Google Scholar
Forte, A, Pompili, M, Imbastaro, B, De Luca, GP, Mastrangelo, M, Montalbani, B, et al. Effects on suicidal risk: comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder. J Psychopharmacol 2021; 35: 1074–80.CrossRefGoogle ScholarPubMed
Peters, E, Shamloo, A, Lodhi, RJ, Marcoux, G, Jackson, K, Halayka, S, et al. Medication gaps and antipsychotic polypharmacy in previously hospitalized schizophrenia patients: an electronic cohort study in three Canadian provinces. Front Psychiatry 2022; 13: 917361.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.